These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Patterns of Care in Patients with Metastatic Renal Cell Carcinoma Among a U.S. Payer Population with Commercial or Medicare Advantage Membership. Miller LA, Stemkowski S, Saverno K, Lane DC, Tao Z, Hackshaw MD, Loy B. J Manag Care Spec Pharm; 2016 Mar; 22(3):219-26. PubMed ID: 27003551 [Abstract] [Full Text] [Related]
4. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. Brixner D, Rubin DT, Mease P, Mittal M, Liu H, Davis M, Ganguli A, Fendrick AM. J Manag Care Spec Pharm; 2019 Jul; 25(7):770-779. PubMed ID: 31081461 [Abstract] [Full Text] [Related]
5. Annual costs among patients with major depressive disorder and the impact of key clinical events. Cutler AJ, Keyloun KR, Higa S, Park J, Bonafede M, Gillard P, Jain R. J Manag Care Spec Pharm; 2022 Dec; 28(12):1335-1343. PubMed ID: 36427344 [Abstract] [Full Text] [Related]
6. LBA02-09 EMBARK: A Phase 3 Randomized Study of Enzalutamide or Placebo Plus Leuprolide Acetate and Enzalutamide Monotherapy in High-risk Biochemically Recurrent Prostate Cancer. J Urol; 2023 Jul; 210(1):224-226. PubMed ID: 37119051 [Abstract] [Full Text] [Related]
7. Sustained long-term benefits of patient support program participation in immune-mediated diseases: improved medication-taking behavior and lower risk of a hospital visit. Fendrick AM, Brixner D, Rubin DT, Mease P, Liu H, Davis M, Mittal M. J Manag Care Spec Pharm; 2021 Aug; 27(8):1086-1095. PubMed ID: 33843252 [Abstract] [Full Text] [Related]
15. Baseline characteristics and secondary medication adherence among Medicare patients diagnosed with transthyretin amyloid cardiomyopathy and/or receiving tafamidis prescriptions: A retrospective analysis of a Medicare cohort. Roy A, Peterson A, Marchant N, Alvir J, Bhambri R, Bredl Z, Benjumea D, Kemner J, Parasuraman B. J Manag Care Spec Pharm; 2022 Jul; 28(7):766-777. PubMed ID: 35737856 [Abstract] [Full Text] [Related]
17. Treatment patterns and health care costs among patients with psoriatic arthritis treated with biologic or targeted synthetic disease-modifying antirheumatic drugs. Murage MJ, Princic N, Park J, Malatestinic WN, Zhu B, Atiya B, Kern SA, Stenger KB, Sprabery AT, Ogdie A. J Manag Care Spec Pharm; 2022 Feb; 28(2):206-217. PubMed ID: 35098751 [Abstract] [Full Text] [Related]
18. Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications. Axon DR, Vaffis S, Chinthammit C, Lott BE, Taylor AM, Pickering M, Black H, Warholak T, Campbell PJ. J Manag Care Spec Pharm; 2020 Dec; 26(12):1529-1537. PubMed ID: 33251989 [Abstract] [Full Text] [Related]
19. Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs. Saundankar V, Peng X, Fu H, Ascher-Svanum H, Rodriguez A, Ali A, Slabaugh L, Young P, Louder A. J Manag Care Spec Pharm; 2016 May; 22(5):467-82. PubMed ID: 27123910 [Abstract] [Full Text] [Related]